Human mast cell β-tryptase is a gelatinase

被引:66
作者
Fajardo, I [1 ]
Pejler, G [1 ]
机构
[1] Swedish Univ Agr Sci, Ctr Biomed, Dept Vet Med Chem, S-75123 Uppsala, Sweden
关键词
D O I
10.4049/jimmunol.171.3.1493
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Remodeling of extracellular matrix is an important component in a variety of inflammatory disorders as well as in normal physiological processes such as wound healing and angiogenesis. Previous investigations have identified the various matrix metalloproteases, e.g., gelatinases A and B, as key players in the degradation of extracellular matrix under such conditions. Here we show that an additional enzyme, human mast cell beta-tryptase, has potent gelatin-degrading properties, indicating a potential contribution of this protease to matrix degradation. Human beta-tryptase was shown to degrade gelatin both in solution and during gelatin zymographic analysis. Further, beta-tryptase was shown to degrade partially denatured collagen type 1. beta-Tryptase bound strongly to gelatin, forming high molecular weight complexes that were stable during SDS-PAGE. Mast cells store large amounts of preformed, active tryptase in their secretory granules. Considering the location of mast cells in connective tissues and the recently recognized role of mast cells in disorders in which connective tissue degradation is a key event, e.g., rheumatoid arthritis, it is thus likely that tryptase may contribute to extracellular matrix-degrading processes in vivo.
引用
收藏
页码:1493 / 1499
页数:7
相关论文
共 47 条
[1]   Inactivation of human lung tryptase: Evidence for a re-activatable tetrameric intermediate and active monomers [J].
Addington, AK ;
Johnson, DA .
BIOCHEMISTRY, 1996, 35 (42) :13511-13518
[2]   INTERACTIONS OF HUMAN MAST-CELL TRYPTASE WITH BIOLOGICAL PROTEASE INHIBITORS [J].
ALTER, SC ;
KRAMPS, JA ;
JANOFF, A ;
SCHWARTZ, LB .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 276 (01) :26-31
[3]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[4]  
BARRETT AJ, 2004, HDB PROTEOLYTIC ENZY
[5]   Human cathepsin O-2, a matrix protein-degrading cysteine protease expressed in osteoclasts - Functional expression of human cathepsin O-2 in Spodoptera frugiperda and characterization of the enzyme [J].
Bromme, D ;
Okamoto, K ;
Wang, BB ;
Biroc, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2126-2132
[6]   New developments in the genetics and activation of mast cell proteases [J].
Caughey, GH .
MOLECULAR IMMUNOLOGY, 2002, 38 (16-18) :1353-1357
[7]   Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis [J].
Coussens, LM ;
Raymond, WW ;
Bergers, G ;
Laig-Webster, M ;
Behrendtsen, O ;
Werb, Z ;
Caughey, GH ;
Hanahan, D .
GENES & DEVELOPMENT, 1999, 13 (11) :1382-1397
[8]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[9]   A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation [J].
Fajardo, I ;
Quesada, AR ;
de Castro, IN ;
Sánchez-Jiménez, F ;
Medina, MA .
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) :17-24
[10]   Formation of active monomers from tetrameric human β-tryptase [J].
Fajardo, I ;
Pejler, G .
BIOCHEMICAL JOURNAL, 2003, 369 :603-610